We have isolated and characterized Xenopus Mxi1, a member of the Myc/Max/Mad family of bHLHZip transcription factors. Xmxi1 transcripts are present during gastrulation and early neurula stages, earlier and in broader domains as compared to the neuronal determination factor neurogenin (X-ngnr-1). Consistent with an early role in neurogenesis, Xmxi1 is positively regulated by Sox3, SoxD, and proneural genes, as well as negatively by the Notch pathway. Loss-of-function experiments demonstrate an essential role for Xmxi1 in the establishment of a mature neural state that can be activated by factors that induce neuronal differentiation, such as SoxD and X-ngnr-1. Overexpression of Xmxi1 in Xenopus embryos results in ectopic activation of Sox3, an early pan-neural marker of proliferating neural precursor cells. Within the neural plate, the neuronal differentiation marker N-tubulin and cell cycle control genes such as XPak3 and p27(Xic1) are inhibited, but the expression of early determination and differentiation markers, including X-ngnr-1 and X-MyT1, is not affected. Inhibition of neuronal differentiation by Xmxi1 is only transient, and, at early tailbud stages, both endogenous and ectopic neurogenesis are observed. While Xmxi1 enhances cell proliferation and apoptosis in the early Xenopus embryo, both activities appear not to be required for the function of Xmxi1 in primary neurogenesis.
Introduction
In Xenopus, the genetic pathway of primary neurogenesis is activated during gastrulation within a field of undifferentiated cells in the induced neuroectoderm, giving rise to three longitudinal domains of neurons on each side of the dorsal midline (Lamborghini, 1980) . Genetic and molecular studies have identified several proneural factors that participate in the conversion of neural precursors into fully differentiated neurons. Most proneural genes exhibit coordinated expression in three bilateral stripes, thereby defining a synexpression group. The temporal order of activation of these regulators represents the successive stages of neuronal determination and differentiation. The earliest gene to be expressed specifically in the domains of primary neurogenesis is the neuronal determination factor neurogenin-related-1 (X-ngnr-1) followed by downstream proneural transcription factors such as X-MyT1, XCoe2 (Ebf2), XEbf3, and NeuroD Bellefroid et al., 1996; Dubois et al., 1998; Pozzoli et al., 2001; Lee et al., 1995) . In addition, several cell cycle regulators have recently been identified in this synexpression group, including XPak3, p27(Xic1), and Gadd45-γ (Souopgui et al., 2002; Carruthers et al., 2003; Vernon et al., 2003; de la Calle-Mustienes et al., 2002) . In contrast to the genetic hierarchy that operates downstream of X-ngnr-1, those that follow neural induction and lead to both the maturation and maintenance of the neural precursor population, as well as control the selection of the proneural territories are not well defined. However, several genes have been implicated in this process, including members of the Sox, Xiro, and Zic transcription factor families (Moody, 2005) . Developmental Biology 292 (2006) 470 -485 www.elsevier.com/locate/ydbio
Members of the Myc/Max/Mad network have been shown to regulate a variety of cellular functions including proliferation, differentiation, and apoptosis. Proteins of this network are characterized by a conserved basic helix-loop-helix-leucine zipper (bHLHZip) domain that facilitates DNA binding and protein dimerization (Grandori et al., 2000; Zhou and Hurlin, 2001) . In general, Myc positively regulates cell proliferation, and the deregulated expression of Myc plays a significant role in the development of human cancers (Nilsson and Cleveland, 2003) . To bind regulatory elements of target genes and to elicit its cellular effects, Myc requires heterodimerization with Max (Grandori et al., 2000; Zhou and Hurlin, 2001 ). Transcriptional activation of target genes is mediated by association of coactivators to conserved motifs in the N-terminus of Myc.
Max also forms heterodimers with the members of the Mad family (Ayer et al., 1993; Zervos et al., 1993; Hurlin et al., 1995) . The Mad proteins (Mad1, Mxi1, Mad3, and Mad4), and the larger and distantly related Mnt (also termed Rox), can antagonize the transforming activity of Myc by sequestering Max, as well as through the binding and repression of a subset of Myc-target genes (Baudino and Cleveland, 2001; O'Hagan et al., 2000; Hurlin et al., 1997; Meroni et al., 1997) . Active repression is achieved by recruitment of complexes containing histone deacetylases to the N-terminal SID domain found in the Mad proteins (Schreiber-Agus et al., 1995; Rao et al., 1996; Alland et al., 1997; Hassig et al., 1997; Laherty et al., 1997) .
Extensive evidence demonstrating that Mxi1 and other members of the Mad family can induce growth arrest and inhibit Myc transformation has been obtained by experiments performed in cell culture systems. However, studies elucidating the functional role of the Mads in normal differentiation processes and in embryonic development remain unclear, as does their contribution to Myc antagonism. Several recent reports have demonstrated that members of the Myc/Mad/Max network can directly control cell fate determination through a mechanism that is independent of proliferation and apoptosis. For example, c-Myc has been shown to be required for neural crest specification in Xenopus, and Mad1 has been identified as a direct activator of the PDX-1 gene in pancreatic β-cells (Bellmeyer et al., 2003; Patane et al., 2003) .
Presently, we report on the isolation and characterization of a novel member of the Mad family of transcriptional repressors in Xenopus, Xmxi1. In gastrula and open neural plate stage embryos, the expression of Xmxi1 coincides with the territories of primary neurogenesis, with Xmxi1 exhibiting earlier and broader expression domains as compared to X-ngnr-1. We demonstrate that Xmxi1 is an essential component of the neurogenesis cascade functioning prior to X-ngnr-1, but downstream of SoxD. In addition, Xmxi1 loss-of-function experiments in animal cap explants demonstrate that ectopic neuralization induced by X-ngnr-1 overexpression is incomplete, as shown by the absence of the pan-neural marker NCAM. This may contribute to the failure of X-ngnr-1 to induce neuronal differentiation in the presence of an Xmxi1 antisense morpholino. In gain-of-function studies, Xmxi1 was demonstrated to participate in the establishment and maintenance of the early neuronal precursor identity through the activation of Sox3. The induction of Sox3 expression occurred concomitantly with inhibition of neuronal differentiation. The inhibition of neuronal differentiation by Xmxi1 was only transient, and, at early tailbud stages, both endogenous and ectopic N-tubulin expression were observed.
Materials and methods

Isolation of Xmxi1
A Xenopus tadpole head λZAP phage cDNA library was used in a largescale whole-mount in situ hybridization screen as described (Souopgui et al., 2002) . The isolated Xmxi1 clone in pBKCMV contained 1314 bp of the 3′-UTR. Rescreening of the library by ECL Direct Nucleic Acid Labeling and Detection System (Amersham Bioscience) afforded a clone with a 2778 bp insert containing the entire coding sequence of Xmxi1, 72 bp of 5′-UTR, and 1891 bp of 3′-UTR including the polyA tail.
Constructs
Xmxi1 and Xmax constructs were prepared by PCR amplification and subcloned into pCS2+ or its derivatives. Human Bcl2 (aa 1-240) was subcloned into EcoRI sites of pRN3. MT-Xmxi1-DBMpCS2 was generated by the QuickChange™XL Site-Directed Mutagenesis Kit (Stratagene) using the following primers: up, 5′-CCCACGAACTGGCGAAGAACCGGAGAGCC-3′ and lower 5′-GGCTCTCCGGTTCTTCGCCAGTTCATTGTGGG-3′, mutation underlined.
Embryo culture and microinjections
Embryos were obtained from Xenopus laevis by HCG-induced egg-laying using standard techniques and staged according to Nieuwkoop and Faber (1967) . Capped mRNA for microinjections was in vitro transcribed (mMessagemMachine™ Ambion) and purified over an RNeasy column (Qiagen). Enzymes used for linearization and transcription, as well as the amount of mRNA injected are indicated: MT-Xmxi (NotI, SP6, 500-750 pg); MT-XMad1 (NotI, SP6, 500 pg); human Bcl2 (SfiI, T3, 500 pg); Xmxi1-GR, MT-Xmxi1-DBM, EnR-Xmxi1, Max (SacII, SP6, 500 pg). The following constructs were previously described: Noggin (50 pg, Smith et al., 1993) ; Notch-ICD (50 pg, Coffman et al., 1993) ; MT-X-ngnr-1 (25 pg, Ma et al., 1996) ; NeuroD (500 pg, Lee et al., 1995); SoxD (200 pg, Mizuseki et al., 1998) ; NLS LacZ (50 pg Chitnis et al., 1995) ; and DNSu(H) (300 pg, Wettstein et al., 1997) . For coinjection experiments, GFP mRNA was used to normalize the mRNA concentrations. As a lineage tracer, 50 pg nuclear lacZ mRNA was coinjected. Embryos were injected in one blastomere of the two-cell stage for mRNA injections. Antisense morpholinos were obtained from Gene Tools LLC. Standard control-MO (Co-MO): 5′-CCTCTTACCT-CAGTTACAATTTATA-3′; Xmxi1-MO 5′-ATCCACCAGCTCCACCGACTC-TAAT-3′; MM-Xmxi1-MO 5′-ATGCACGAGCTGCACCCACTGTAAT-3′; Xmxi1-MO2 5′-TCCATCATCTCCTGCAGCTCCATCA-3′; X-ngnr-1-MO 5′-TGGTTAGCCCCAATGTTGCACTGAC-3. For in vitro and in vivo MO specificity experiments, see Supplementary Material.
Chemical treatment of embryos
Embryos were incubated with dexamethasone (4 μg/ml in 0.1× MBSH) at various stages until fixation (Kolm and Sive, 1995) . HUA treatment was performed as described (Hardcastle and Papalopulu, 2000) .
Whole-mount in situ hybridization and histology X-gal staining was performed as described (Hardcastle and Papalopulu, 2000) . Whole-mount in situ hybridization was performed essentially as described (Harland, 1991; Hollemann and Pieler, 1999) using antisense RNA labeled with digoxygenin-11-UTP. Double in situ hybridization was performed according to Knecht et al. (1995) . Sox3 was labeled with fluorescein and stained with FastRed (Roche) and Xmxi1 with digoxygenin and NBT/BCIP. Enzymes used for linearization and transcription are indicated: Xmxi1pGEM-T (BamHI, T7); Sox3pBS (EcoRI/T7); and EpiKpGEM-T (XK81) (EcoRI/T7). The following constructs were previously described: XPak3 (Souopgui et al., 2002) ; X-ngnr-1 ; X-MyT1 (Bellefroid et al., 1996) ; N-tubulin (Chitnis et al., 1995) ; NeuroD (Lee et al., 1995) ; X-Delta1 (Chitnis et al., 1995) ; ESR9 (Li et al., 2003) ; and p27(Xic1) (Ohnuma et al., 1999) .
Specimens were embedded in a gelatin/albumin mixture, and sections (30 μm) were cut on a Leica VT1000M vibratome (Hollemann and Pieler, 1999) .
Proliferation and TUNEL assays
The BrdU assay was performed as described by Hardcastle and Papalopulu (2000) with the following exception: undiluted BrdU solution (8 nl) was bilaterally injected dorsally and once into the ventral hemisphere of stage 15 embryos and fixed 1 h later. The pH3 and TUNEL assays were performed as described (Dent et al., 1989; Hensey and Gautier, 1997) .
Animal cap dissections and real-time RT-PCR Two-cell stage embryos were injected bilaterally, animal caps dissected from stage 8 to 9 embryos and cultured until sibling controls reached the desired stage. Total RNA was prepared with RNAqueous-Micro Kit (Ambion). cDNA was prepared using random hexamer primers in 100 μl total volume containing 500 ng of total RNA, and a 5 μl aliquot was assayed in a total volume of 50 μl by real-time PCR with iQ Sybr Green Supermix in the iCycler system (BioRad). All samples were normalized to levels of ornithine decarboxylase (ODC), which was used as the loading control. The mRNA concentration was measured by using a standard curve for each analyzed gene. All measurements were done in duplicates, and the values in the figures represent the mean of a representative experiment. For a list of primer sequences and PCR conditions, see Supplementary Material.
Results
Cloning and expression of Xmxi1
In a large-scale expression screen aimed at identifying novel Xenopus genes in the context of neurogenesis, one clone exhibited broad expression throughout the territories of primary neurogenesis (Souopgui et al., 2002) . As the isolated clone did not contain an open reading frame, a Xenopus head cDNA library was screened, and an overlapping clone harboring 2778 bp of cDNA sequence was obtained. This isolated cDNA sequence encoded for a protein of 238 amino acids containing a SID repressor domain and a bHLHZip domain characteristic of the Mad family of Myc antagonist proteins.
We termed our isolated gene Xmxi1 as the deduced protein sequence was most closely related to other vertebrate Mxi1 proteins. In mouse and human, three isoforms of Mxi1 have been identified (Fig. 1A ) (Dugast-Darzacq et al., 2004; Engstrom et al., 2004) . The most characterized isoform Mxi1-SRβ is both a strong transcriptional repressor and growth suppressor. Mxi1-WR is identical to Mxi1-SRβ with the exception that it does not harbor the N-terminal 36 amino acids encoding for the SID domain and thus lacks these activities. Mxi1-SRα (also termed Mxi1-O) has an extended N-terminus and a slightly different SID domain compared with Mxi1-SRβ. Alignment of the Xenopus protein and the mouse Mxi1 isoforms revealed an identity between 58 and 64% over the entire protein, with higher regions of homology found within the SID repressor (70%) and the bHLH domains (86%) (Fig. 1A) . The overall homology with other mouse members of the Mad family was much lower (20-50%).
The temporal expression of Xmxi1 was investigated by RT-PCR analysis with RNA isolated from various stages of Xenopus development (Fig. 1B) . Maternal transcripts of Xmxi1 were detected at low levels but increased during gastrula stages and were maintained at constant levels throughout neurogenesis and later development. The temporal expression of Xmxi1 was unique in comparison with other Xenopus members of the Mad family. Transcripts of Xmad1 and Xmad3 are expressed at relatively constant levels during embryogenesis, while those of Xmnt and Xmad4 decrease during neurula stages (Juergens et al., 2005; Newman and Krieg, 1999) .
Xmxi1 mRNA was first detected by whole-mount in situ hybridization analysis broadly throughout the dorsal ectoderm during gastrulation. The expression of Xmxi1 is very similar to one of the earliest proneural genes, X-ngnr-1 . As shown in Fig. 1C , a direct comparison of their expression patterns during gastrulation reveals that Xmxi1 expression domains are much broader and prefigure the domains of primary neurogenesis demarcated by X-ngnr-1. At stage 13 in the posterior neural plate, transcripts are localized in three broad stripes on both sides of the dorsal midline encompassing the medial, intermediate and lateral proneural domains that will later give rise to the motor-, inter-and sensory neurons, respectively (Fig. 1G ). Xmxi1 transcripts are also found in additional cell populations of the anterior neural plate that express other proneural genes including the trigeminal and olfactory placodes, as well as cells of the future ventral midbrain and hindbrain. Double labeling of stage 14 embryos with Xmxi1 and Sox3, a pan-neural marker expressed in proliferating cells, showed that their expression domains are partially overlapping, including the different layers of the posterior neuroectoderm (Figs. 1D-F). In contrast to Sox3, Xmxi1 is excluded from the anterior neural plate, a territory in which neuronal differentiation is delayed until the tadpole stage (Papalopulu and Kintner, 1996) . Moreover, the lateral stripe of Xmxi1, similar to that of the neuronal differentiation marker N-tubulin, is outside of the territory stained by Sox3 ( Fig. 1E , arrowhead) (Bellefroid et al., 1998) . During later neurula stages, Xmxi1 continued to be broadly expressed throughout the neural plate but was excluded from the anterior neural folds (Fig. 1H) . A transversal section of a stage 16 embryo revealed that Xmxi1 transcripts are now predominately restricted in the sensorial layer of the neuroectoderm where primary neurogenesis occurs ( Fig. 1I) (Hartenstein, 1989) . At stage 27, Xmxi1 expression was detected throughout the CNS including the eye, the olfactory placodes, midbrain, hindbrain, and spinal cord (Fig. 1K) . In a transversal section of a stage 37 embryo, expression of Xmxi1 in the eye was restricted to the retina (Fig. 1M ), while the expression in the neural tube was located in the proliferating neural progenitors of the ventricular zone and the intermediate zone, where cells start to differentiate (Fig. 1N) . 
Regulation of Xmxi1
An early role for Xmxi1 in the regulation of primary neurogenesis is strongly suggested by both the temporal and spatial expression of Xmxi1. To study the regulation of Xmxi1, known positive and negative regulators of neurogenesis were evaluated for their influence on Xmxi1 expression in whole embryos. mRNAs encoding regulatory factors were injected into one blastomere of two-cell stage embryos together with LacZ mRNA to localize the distribution of the injected mRNA. As shown in Figs. 2A and B, the pan-neural HMG-box transcription factor Sox3 ectopically activates Xmxi1 expression (96%, n = 23), while it inhibits the neuronal differentiation marker, N-tubulin (92%, n = 60). X-ngnr-1 also ectopically activates Xmxi1 expression (100%, n = 37), which is similar to its effect on N-tubulin (Figs. 2C, D). The downstream proneural transcription factor NeuroD also strongly induces Xmxi1 within the neural plate, as well as in the nonneural ectoderm (87%, n = 45) (Fig. 2E) .
In addition to its proneural activity, X-ngnr-1 activates the Notch pathway, which restricts the number of cells that undergo neuronal differentiation. To determine the influence of Notch signaling on the expression of Xmxi1, Notch signaling was increased or decreased by overexpression of the intracellular , X-ngnr-1-MO (15 ng), X-ngnr-1 (25 pg), and control-MO (Co-MO) (15 ng), as indicated, cultured until sibiling embryos reached stage 14 and subject to real-time RT-PCR analysis. Expression levels were normalized to ornithine decarboxylase (ODC) and compared to the induction capacity of SoxD, which was set to 10. Note that X-ngnr-1 RT primers detect both endogenous and injected X-ngnr-1 RNA.
domain of XNotch1 (Notch-ICD) or a dominant-negative version of X-Su(H) mutated in the DNA binding domain (DN-SuH) (Chitnis et al., 1995; Wettstein et al., 1997) . Injection of mRNA encoding Notch-ICD negatively regulated Xmxi1 (96%, n = 24) expression, as well as X-ngnr-1 (Figs. 2G, H) . Conversely, DN-SuH increased the density of Xmxi1 (92%, n = 27) and X-ngnr-1 in the domains of primary neurogenesis (Figs. 2I, J ). These results demonstrate that Xmxi1 is negatively regulated by lateral inhibition.
The regulation of Xmxi1 was also investigated in ectodermal explants (animal caps) from blastula stage embryos; these explants are normally fated to become epidermal tissue but can be converted to derivatives of all three germ layers. The animal blastomeres of two-cell stage Xenopus embryos were injected bilaterally with mRNA, and animal caps were dissected at blastula stage. Total RNA was isolated at stage 14 and analyzed by RT-PCR. As shown in Fig. 2K , while animal caps neuralized with the BMP inhibitor noggin afford a strong induction of the pan-neural markers Sox3 and NCAM, but Xmxi1 transcript levels did not significantly increase. While Sox3 overexpression in whole embryos afforded ectopic activation of Xmxi1 ( Fig.  2A) , the Sox3 levels induced by noggin maybe insufficient for activation in animal caps. Consistent with its ability to activate Xmxi1 in the nonneural ectoderm of whole embryos, X-ngnr-1 robustly activated not only N-tubulin and NCAM, but also Xmxi1. Interestingly, Sox3 was not induced by X-ngnr-1 in the animal cap assay, as well as in whole embryos ( Fig. 2K and data not shown). This may reflect the incompatibility with neuronal differentiation as previously suggested by their mutual exclusive expression patterns (Bourguignon et al., 1998; Bellefroid et al., 1998) . We also investigated the regulation of Xmxi1 by SoxD, an early pan-neural transcription factor that can induce both neural and neuronal differentiation in ectodermal explants (Mizuseki et al., 1998) . As shown in Fig.  2K , SoxD activates Xmxi1, but as overexpression of SoxD also increases the levels of X-ngnr-1, activation of Xmxi1 may be indirect (Yeo and Gautier, 2005) .
Therefore, we asked if the induction of Xmxi1 transcripts by SoxD was maintained in the absence of X-ngnr-1. Towards this end, an antisense morpholino oligonucleotide (MO) that is expected to inhibit the translation of the endogenous X-ngnr-1 was designed (Heasman, 2002) . The X-ngnr-1-MO, but not a control-MO, inhibited translation of X-ngnr-1 mRNA in an in vitro coupled transcription/translation reaction (Supplementary Material). Correspondingly, in whole embryos, the X-ngnr-1-MO inhibited neuronal differentiation on the injected side (loss of N-tubulin, 85%, n = 39) (Fig. 2L) . The control-MO did not alter the expression of N-tubulin (data not shown). Moreover, the loss of N-tubulin expression by the X-ngnr-1-MO could be rescued by coinjection with X-ngnr-1 mRNA (no loss of Ntubulin plus ectopic N-tubulin, 100%, n = 110) (Fig. 2M) .
As shown by real-time RT-PCR analysis, overexpression of SoxD alone or in combination with the X-ngnr-1-MO increased Xmxi1 transcript levels in animal caps to the same extent. However, as anticipated, the X-ngnr-1-MO, but not the control-MO, inhibited SoxD induction of N-tubulin (Fig. 2N ). This loss of N-tubulin expression was not due to inhibition of X-ngnr-1 transcript levels and could be rescued by coinjection of X-ngnr-1 mRNA, further demonstrating specificity of the MO. The above results show that Xmxi1 is regulated by pan-neural and proneural genes further, supporting an early role for Xmxi1 in the context of primary neurogenesis.
Xmxi1 is essential for primary neurogenesis
The requirement of Xmxi1 during primary neurogenesis was evaluated using an MO to inhibit translation of the endogenous Xmxi1. The specificity of the MO was demonstrated by the inhibition of translation of an Xmxi1 5′-UTR-GFP fusion mRNA in Xenopus embryos by the Mxi1-MO, but not a GFP mRNA lacking the MO target site (Supplementary Material). A specific control mismatch MO (MM-Xmxi1-MO) did not alter translation of either RNA.
Injection of the Xmxi-MO (12.5 ng) into one dorsal blastomere of four-cell stage embryos led to an inhibition of neuronal differentiation, as marked by N-tubulin (86%, n = 67) (Fig. 3A) . The MM-Xmxi1-MO did not alter N-tubulin expression (100%, n = 48) (Fig. 3H ). The suppression of Ntubulin by the Xmxi1-MO was not due to the loss of the neural precursor cell population as Sox3 expression was not significantly altered (93%, n = 23) (Fig. 3D) . However, the early proneural genes X-ngnr-1 (72%, n = 79) and X-MyT1 (80%, n = 15) were both inhibited by the Xmxi1-MO (Figs.  3B, C ). To further demonstrate specificity of the loss-offunction phenotype, an additional MO (Xmxi1-MO2) was used which recognizes a different target site. Consistently, the Xmxi1-MO2 also inhibited expression levels of X-ngnr-1 (71%, n = 76), X-MyT1 (73%, n = 63), and N-tubulin (85%, n = 79) (Figs. 3E-G) .
The loss of X-ngnr-1 expression could be rescued by coinjection of MT-Xmxi1 (500 pg) together with the morpholino, further demonstrating specificity of the MO (65%, n = 110 of the embryos exhibited no reduction of X-ngnr-1 on the injected side) (Fig. 3I ). However, it should be noted that attempts to rescue the morpholino-induced inhibition of Ntubulin by titrating the concentration of Xmxi1 was not possible, even with doses as low as 5 pg. The failure to rescue the loss of N-tubulin expression may partially be attributed to the finding that MT-Xmxi1 overexpression results in a transient inhibition of neuronal differentiation downstream of X-ngnr-1 (see below).
As SoxD is expressed earlier than Xmxi1 and as SoxD activates transcription of both Xmxi1 and X-ngnr-1 (Fig. 2K and Mizuseki et al., 1998) , we asked if Xmxi1 is required for the function of SoxD. In whole embryos, overexpression of SoxD afforded a strong ectopic activation of X-ngnr-1 (ectopic Xngnr-1, 90% n = 20) that was effectively inhibited by the presence of the Xmxi1-MO (ectopic X-ngnr-1 with much weaker staining than SoxD alone, 30% n = 23) (compare Figs. 3J, K). Moreover, this inhibition could be rescued by coinjection of MT-Xmxi1 (ectopic X-ngnr-1, 84% n = 19) (Fig. 3L) .
To further provide evidence that Xmxi1 is required for SoxD function, we used the animal cap assay coupled with real-time RT-PCR analysis. SoxD induced both the panneural markers Nrp-1 and NCAM, as well as X-ngnr-1 and N-tubulin (Fig. 3M) . However, in the presence of the Xmxi1-MO, but not the control-MO, the activation of Xngnr-1 by SoxD was significantly inhibited. Consistent with the results obtained in the whole embryo, the inhibitory effect of the Xmxi1-MO could be rescued by coinjection of MT-Xmxi1. In addition, the Xmxi1-MO suppressed the The results obtained thus far argue for a role of Xmxi1 upstream of the proneural genes. However, as shown in Fig. 2C , X-ngnr-1 ectopically activates Xmxi1, suggesting that Xmxi1 may also have a function downstream of the proneural genes. To investigate this possibility, we employed the animal cap assay and real-time RT-PCR analysis. In the presence of the Xmxi1-MO but not the control-MO, the X-ngnr-1 induction of the downstream proneural genes (X-MyT1 and NeuroD) and Ntubulin was inhibited (Fig. 4) . However, X-ngnr-1 not only induces neuronal differentiation mediated by the proneural genes, but also induces neuralization, as illustrated by the activation of general pan-neural markers such as Nrp-1 and NCAM. Interestingly, the Xmxi1-MO slightly reduced activation of Nrp-1 by X-ngnr-1, but NCAM, which marks the mature neural cells, was strongly inhibited (Fig. 4) (Sasai, 2001 ). These results are consistent with the notion that Xmxi1 is an essential component of neurogenesis required to obtain a mature neural state that can respond to factors that induce neuronal differentiation.
Xmxi1 overexpression delays the process of primary neurogenesis
To further study the role of Xmxi1 in the context of primary neurogenesis, gain-of-function experiments in Xenopus embryos were performed. As mammalian members of the Myc and Mad families have been found to exert a short half-life in cell culture (Hann and Eisenman, 1984; Ayer et al., 1993) , we checked the stability of Mxi1 in Xenopus embryos by injecting mRNA encoding for Xmxi1 bearing an Myc epitope (MT) at the N-terminus. Western blot analysis revealed constant protein levels of MT-Xmxi1 throughout gastrulation and early neurula stages, but, by stage 20, it is no longer detected (Supplementary Material).
Injection of MT-Xmxi1 mRNA (500 pg) into the animal pole of one blastomere at the two-cell stage negatively influenced neuronal differentiation, as shown by the loss of N-tubulin expression on the injected side of the embryo (70%, n = 134) (Fig. 5A) . The inhibition of primary neurogenesis was not the result of loss of the neural precursor pool as Sox3 expression was not reduced but dramatically expanded and found in the nonneural ectoderm of the injected side (77%, n = 128) (Fig.  5B) . The increase in Sox3 expression occurred at the expense of epidermis, as shown by the loss of epidermal keratin expression (72%, n = 22) (Fig. 5C) . Thus, Xmxi1 and Sox3 exhibit positive reciprocal regulation (Figs. 2A, 5B) .
As all members of the Mad family have closely related SID repressor and bHLHZip domains, we therefore asked if the overexpression phenotype observed is unique to Xmxi1. The bHLH and SID domains of Xmad1 exhibit 76% and 80% identity compared to the corresponding domains in Xmxi1, but the overall homology is much lower (53%). Moreover, in contrast to Xmxi1, which is found primarily in proliferating tissue, Xmad1 is predominately found in post-mitotic cells (Juergens et al., 2005) . Several experiments support that the Fig. 4 . Xmxi1 is required for X-ngnr-1-induced neuronal differentiation. Animal caps were isolated from embryos injected with X-ngnr-1 (20 pg), Xmxi1-MO (12.5 ng), Co-MO (12.5 ng), and MT-Xmxi1 (500 pg) as indicated and analyzed by real-time RT-PCR. Expression levels were normalized to ODC and were compared to the induction capacity of X-ngnr-1-injected animal caps, which was set to 10. observed ectopic activation of Sox3 and inhibition of neuronal differentiation by MT-Xmxi1 are most likely not due to an unspecific activity, such as the binding to non-target E-box sequences, the sequestration of Max or other bHLH transcription cofactors. First, MT-Xmad1 (500 pg) did not alter the expression of N-tubulin or Sox3 (N-tubulin, 83%, n = 34; Sox3, 83%, n = 18) (Figs. 5D, E) . In addition, the activity of Xmxi1 was found to be dependent on its ability to bind DNA. Overexpression of MT-Xmxi1 containing a point mutation in the basic domain that is expected to disrupt DNA binding (MTXmxi1-DBM) did not induce ectopic activation of Sox3 and inhibition of N-tubulin expression (no effect, N-tubulin 86%, n = 87; Sox3, 82%, n = 93) (Figs. 5F, G) (Fisher et al., 1993; Prochownik et al., 1998) . Moreover, coinjection of MT-Xmxi1 together with Max did not alter the effect of Xmxi1 on primary neurogenesis (inhibition of N-tubulin, 80%, n = 21, ectopic Sox3, 76%, n = 21) (Figs. 5H, I ).
To determine if the SID repressor domain was required for Xmxi1 function in the context of primary neurogenesis, the SID repressor domain was removed. Overexpression of mRNA encoding MT-ΔNXmxi1 (500 pg) also did not alter the expression of Sox3 or N-tubulin, demonstrating the necessity of the repressor domain (no effect, N-tubulin, 92%, n = 25; Sox3, 80%, n = 50) (Figs. 5J, K) . Correspondingly, replacement of the SID domain with a heterologous repressor domain derived from Engrailed Repressor (EnR-Xmxi1) (Jaynes and O'Farrell, 1991) functioned in a similar manner to MT-Xmxi1, inducing ectopic Sox3 expression concomitant with a loss of epidermal keratin and N-tubulin expression (Sox3, 70%, n = 46 ectopic; EpiK, 82%, n = 11 reduced; N-tubulin, 78%, n = 32 reduced) (Figs. 5L-N) .
Expansion of the neural plate and inhibition of neuronal differentiation are similar to the phenotype observed upon activation of Notch signaling (Coffman et al., 1993) . However, the expression patterns of the Notch ligand XDelta1 (100%, n = 10) and ESR9 (75%, n = 12), a direct Notch target gene, were not altered on the side injected with MT-Xmxi1 mRNA (Figs. 6A, B) . In addition, MT-Xmxi1 had no significant effect on early proneural markers such as Xngnr-1 (83%, n = 30), X-MyT1 (78%, n = 32), and NeuroD (67%, n = 27) (Figs. 6C-E) . The EnR-Xmxi1 afforded similar results as MT-Xmxi1, with the exception that NeuroD was suppressed in a significant percentage of the embryos (no change on the injected side, X-Delta1 94%, n = 17; ESR9 74%, n = 19; X-ngnr-1 100%, n = 20, X-MyT1 88%, n = 16 and downregulated on the injected side NeuroD 67%, n = 18) (Supplementary Material).
As the process of neuronal differentiation is tightly coupled with cell cycle withdrawal and Xmxi1 ectopically activates Sox3, a marker that coincides with neural cell proliferation, the influence of Xmxi1 on the expression of factors known to regulate cell cycling in the context of primary neurogenesis was investigated. MT-Xmxi1 inhibited the expression of p21-activated kinase 3 (XPak3) (82%, n = 55) and the cdk inhibitor p27(Xic1) (77%, n = 44), which are required for cell cycle exit and differentiation of primary neurons (Figs. 6F, G) (Souopgui et al., 2002; Carruthers et al., 2003; Vernon et al., 2003) . As shown in the transversal section in Fig. 6H , MT-Xmxi1 inhibited p27(Xic1) in the neuroectoderm, as well as in the myotome, suggesting that this may be a direct effect on p27(Xic1).
The results obtained by the gain-of-function experiments suggest that Xmxi1 expands the precursor population and inhibits differentiation events downstream of the early proneural transcription factors at the open neural plate stage. To gain additional support for this mechanism of action by Xmxi1, we employed the animal cap assay in combination with real-time RT-PCR. Injection of mRNA encoding for X-ngnr-1 in early cleavage embryos prior to explant preparation is sufficient to drive this nonneural ectoderm into differentiated neural tissue (Fig. 6I) . Coinjection of MT-Xmxi1 together with X-ngnr-1 did not alter the induction of early target genes of X-ngnr-1, such as Ebf2, XMyT1 and NeuroD or ESR9; however, X-ngnr-1-mediated activation of the late target genes XEbf3, XPak3, and Ntubulin was inhibited.
Taken together, the results obtained thus far suggest that Xmxi1 maintains an early neuronal precursor state in neural ectoderm, resulting in the inhibition of neuronal differentiation at the open neural plate stage. We next evaluated if this inhibition was transient, as has been observed for SoxD (Yeo and Gautier, 2005; Mizuseki et al., 1998) . The ability of MTXmxi1 to influence neural and neuronal differentiation markers in both naive and neuralized animal caps was compared by use of animal caps that were cultured until siblings had reached stage 14 (early) or stage 20 (late) and analyzed by real-time RT-PCR. As shown in Fig. 7A , in early animal caps, MT-Xmxi1 weakly induces Sox3 and Nrp-1 but did not significantly alter the transcript levels of SoxD and NCAM. In contrast, the neural inducer noggin strongly activates all four pan-neural markers. Moreover, in early caps, noggin and Xmxi1 alone or in combination did not induce X-ngnr-1 or N-tubulin. In late stage MT-Xmxi1-injected caps, the levels of Sox3 and Nrp-1 declined, but those of SoxD and NCAM were not altered. However, both X-ngnr-1 and N-tubulin were induced. The activation of X-ngnr-1 and N-tubulin was even stronger when Real-time RT-PCR analysis of animal cap explants isolated from embryos injected with X-ngnr-1 (25 pg) alone or together with MT-Xmxi1 (500 pg). Expression levels were normalized to ODC and compared to the induction capacity of X-ngnr-1 injected animal caps, which were set to 10.
Xmxi1 was coinjected with noggin. Animal caps treated with noggin alone did not strongly activate these markers.
To further confirm these results, we evaluated MT-Xmxi1-injected embryos at the early tailbud stage. As shown in Figs. 7B-E, on the injected side, most embryos have small protrusions suggesting Xmxi1 may also increase proliferation. The ectopic Sox3 (45%, n = 32) staining observed at the open neural plate stage persisted, with a reduced extent and percentage as compared to early neurula stages. The inhibition of N-tubulin was found to be transient as wild-type levels were observed on the injected side of the neural tube. In addition, a limited amount of ectopic N-tubulin staining was detected (60%, n = 25). Interestingly, as shown by Western blot analysis (Supplementary Material), by stage 22, the MT-Xmxi1 protein is no longer detectable, suggesting that high levels of Xmxi1, similar to Sox3, may be incompatible with neuronal differentiation. At lower Xmxi1 concentrations (5-50 pg), an increase in neuronal differentiation was not observed (data not shown). However, at these lower concentrations, Sox3 was also not induced. Therefore, Xmxi1 can only induce a delayed neuronal differentiation in neuralized tissue consistent with the animal cap experiments.
Effects of Xmxi1 on proliferation and apoptosis
To determine if Xmxi1 inhibits neuronal differentiation at neurula stages by increasing proliferation as suggested by inhibition of cell cycle regulator gene expression and activation of Sox3, mitotic cells of MT-Xmxi1-injected embryos were stained with the antibody against phosphorylated histone H3 (pH3). The number of pH3-positive cells in the neural plate of the injected side was compared with the uninjected side in serial sections. While sections from control embryos did not differ significantly in the number of pH3-positive cells on each side of the midline, overexpression of mRNA (500 pg) encoding for MT-Xmxi1 and EnR-Xmxi1 almost doubled the number of pH3-positive cells compared with the uninjected side (Fig. 8A) . A hormone-inducible version of Xmxi1, generated by fusion of the ligand-binding domain of the glucocorticoid receptor (GR) to the C-terminus of Xmxi1 (Xmxi1-GR), was created (Gammill and Sive, 1997) . Activation of this construct by treatment of the injected embryos at stage 10.5 with dexamethasone induced ectopic Sox3 and inhibition of neuronal differentiation (Fig. 8C) , as well as increased proliferation on the injected side (Fig. 8A) . Moreover, injection of the Xmxi1-MO, but not of the control- MO significantly decreased cell cycling on the injected side. We also injected a lower concentration to determine if the effect of Xmxi1 on cell proliferation was maintained at lower concentrations. However, injection of a low dose of MT-Xmxi1 (50 pg) did not alter the number of pH3-positive cells on the injected side or the expression of Sox3 and N-tubulin (data not shown).
As Mxi1 overexpression results in the accumulation of glioblastoma and prostate carcinoma cells in the G2/M phase, which would also result in an increase of pH3-positive cells, we also measured BrdU incorporation to further evaluate the role of Xmxi1 on proliferation (Manni et al., 2002; Taj et al., 2001; Wechsler et al., 1997) . Consistent with the results obtained by pH3 staining, the MT-Xmxi1, EnR-Xmxi1 or Xmxi1-GR fusion constructs nearly doubled the number of BrdU-positive cells on the injected side, while the Xmxi1-MO, but not the control-MO, decreased the number of positive cells (Fig. 8B) .
These results suggest that Xmxi1 may maintain an undifferentiated neural state by activation of proliferation. We therefore asked if the ectopic Sox3 and inhibition of N-tubulin expression as observed upon overexpression of Xmxi1 could be inhibited by forceful cell cycle arrest achieved through the treatment of the injected embryos with a cocktail of hydroxyurea and aphidicolin (HUA) (Harris and Hartenstein, 1991) . The effectiveness of the inhibitors was verified by the failure of embryos to gastrulate when treated at stage 8. Embryos treated at stage 10 developed normally up to open neural plate stages but exhibited strongly reduced pH3 staining, further demonstrating the effectiveness of treatment (Fig. 8C) . Ectopic Sox3 and inhibition of N-tubulin expression was still observed when the Xmxi1-GR-injected embryos were treated with HUA at stage 10 and induced with dexamethasone at stage 10.5 (−HUA, ectopic Sox3, 72%, n = 19, inhibition N-tubulin 86%, n = 31; +HUA, ectopic Sox3, 74%, n = 15, inhibition N-tubulin 76%, n = 24). These results suggest that both the Xmxi1-mediated induction of Sox3 and concomitant downregulation of Ntubulin do not directly depend on an increase in cellular proliferation.
An alternative mechanism for the absence of post-mitotic neurons upon overexpression of Xmxi1 could be due to the loss of these cells by apoptosis. The effect of Xmxi1 on programmed cell death during primary neurogenesis was therefore evaluated by TUNEL staining. As shown in Fig. 8D , injection of mRNA encoding for MT-Xmxi1 increased the amount of cells undergoing apoptosis. The increased number of apoptotic cells is most likely not sufficient to account for the loss of Ntubulin expression. To address if Xmxi1-induced apoptosis contributes to the activity of Xmxi1 during neurogenesis, MTXmxi1 was coinjected with the apoptosis inhibitor Bcl2. Bcl2 alone slightly increased neuronal differentiation, as reported previously (Yeo and Gautier, 2003) (data not shown). However, coinjection of human Bcl2 (500 pg) with MT-Xmxi1 did not alter the ability of MT-Xmxi1 to inhibit N-tubulin expression but was sufficient to block MT-Xmxi1-induced apoptosis (−Bcl2, ectopic Sox3, 76%, n = 34, inhibition N-tubulin 82%, n = 25; +Bcl2, ectopic Sox3, 73%, n = 32, inhibition N-tubulin 84%, n = 25) (Fig. 8D ). These results demonstrate that, while both cell proliferation and apoptosis are induced by Xmxi1, both activities appear not to be necessary for the activation of Sox3 and inhibition of neuronal differentiation, suggesting that Xmxi1 may have a direct influence on cell fate.
Discussion
In this study, we report on the identification of a novel Xenopus Mad family member and its role in the context of neurogenesis. Xmxi1 is expressed broadly throughout the domains of primary neurogenesis during early embryogenesis, and, at later developmental stages, the expression is maintained throughout the CNS. Consistent with the early expression of Xmxi1 transcripts during Xenopus primary neurogenesis, we have found that Xmxi1 plays an essential role in the formation of a mature neural fate, which can be acted upon by factors that induce neuronal differentiation.
A summary of the obtained results and the relationship of Xmxi1 with known components of the neurogenesis network are shown in Fig. 9 . Consistent with an early role in the context of neurogenesis, Xmxi1 was positively regulated by the panneurally expressed HMG-box transcription factors Sox3 and SoxD. Through loss-of-function experiments, Xmxi1 was shown to be required for the endogenous expression of Xngnr-1 and consequently neuronal differentiation, as well as for SoxD-induced activation of Nrp-1, NCAM, and X-ngnr-1. While Xmxi1 is required for neurogenesis, overexpression of Xmxi1 at high concentration inhibits neuronal differentiation, which may be the result of Sox3 induction and maintenance of an early neural cell fate. X-ngnr-1 and its early proneural target genes, such as X-MyT1 and Ebf2, are not inhibited by overexpression of Xmxi1, but the expression of late acting differentiation genes such as Ebf3 and those required for cell cycle withdrawal of the progenitors including XPak3 and p27 (Xic1) are inhibited. Suppression of neuronal differentiation is only transient, and, at later developmental stages, the expanded precursor population, perhaps due to a decline in concentration of Xmxi1 or Sox3, can undergo neuronal differentiation. In addition, Xmxi1 is also positively regulated by X-ngnr-1 and NeuroD. While Xmxi1 may have an additional role downstream Fig. 9 . Scheme representing the role of Xmxi1 during primary neurogenesis in Xenopus. Neural induction by BMP inhibitors leads to the activation of several panneural expressed genes including Sox3 and SoxD. In turn, SoxD can activate Xmxi1, which is required for SoxD-induced activation of NCAM, Nrp-1, X-ngnr-1, and neuronal differentiation. Xmxi1 transiently inhibits neuronal differentiation downstream of the proneural genes (red dashed arrow), which may be the result of Sox3 activation. At later stages, Xmxi1 can induce neuronal differentiation (black dashed arrow). Xmxi1 is also activated by proneural genes such as X-ngnr-1 and NeuroD. In the absence of Xmxi1, X-ngnr-1 does not completely neuralize the ectoderm, and neuronal differentiation is inhibited.
of X-ngnr-1, our studies support the requirement of Xmxi1 in establishing a mature neural fate, which is required prior to the initiation of neuronal differentiation. This hypothesis is supported in animal cap experiments, whereby, in the absence of Xmxi1, the complete neuralization of the ectoderm by Xngnr-1 as marked by Nrp-1 and NCAM is inhibited, as well as neuronal differentiation.
Several prepattern genes have been identified that bridge the events of neural induction with the downstream acting proneural genes. However, the epistatic relationship and the molecular mechanism by which these factors act are for the most part unknown. Members of the SoxB1 and Zic families have been found to participate in the early establishment and stabilization of a neural fate. SoxD and members of the Xiro family, in contrast, act as late stabilizing genes, positively regulating the proneural genes and promoting neuronal differentiation (Penzel et al., 1997; Kuo et al., 1998; Brewster et al., 1998; Mizuseki et al., 1998; Bellefroid et al., 1998; Gomez-Skarmeta et al., 1998) . As only a restricted number of cells within the neuroectoderm will exit the cell cycle and commence differentiation (Hartenstein, 1989) , one intriguing question is how the three bilateral longitudinal primary neurogenesis domains are selected by these broadly expressed prepattern genes. Zic2 inhibits neuronal differentiation and may contribute to this process, particularly at late neurula stages where it is expressed in the posterior region of the neural plate in domains that alternate with stripes of the proneural genes (Brewster et al., 1998) . However, during gastrulation and early neurula stages, Zic2 is expressed broadly throughout the prospective neural ectoderm (Brewster et al., 1998) , suggesting the involvement of additional factors.
Most identified proneural genes exhibit coordinated expression in the discrete domains of primary neurogenesis. The temporal expression of the genes within these domains correlates with their function. Early expressed genes tend to act as determination factors while later expressed genes function in differentiation. Moreover, a refinement of the proneural domains is also observed. For example, the expression of X-ngnr-1 is much broader than downstream differentiation factors such as XMyT1, which is expressed in slightly larger domains than Ntubulin (Bellefroid et al., 1996) . As described above, it remains elusive as to how the known prepattern genes can account for the restricted expression of the proneural genes. Based on the expression of Xmxi1 and its requirement for SoxD function, Xmxi1 is an ideal candidate to participate in this process.
In naive animal caps, the effectiveness of Xmxi1 in promoting ectopic neuronal differentiation was low. However, in neuralized animal caps, the ability of Xmxi1 to induce neuronal differentiation was much stronger, suggesting the existence of coacting factors such as SoxD and other prepattern genes that act synergistically or in parallel. The gain-of-function phenotype of Xmxi1 was similar to that of SoxD, i.e. the transient inhibition of neuronal differentiation at the open neural plate stage with ectopic neurons at the tailbud stage (Yeo and Gautier, 2005; Mizuseki et al., 1998) . Albeit, SoxD is much more effective in inducing ectopic neuronal differentiation compared with Xmxi1.
In Xmxi1-injected embryos, at the open neural plate stage, an inhibition of neuronal differentiation was observed concomitant with ectopic activation of a marker of proliferating neural progenitor cells, Sox3. A correlation of ectopic Sox3 activation with inhibition of neuronal differentiation at the open neural plate stage followed by ectopic neurogenesis at later stages has been observed during primary neurogenesis in Xenopus (Bellefroid et al., 1998; Voigt et al., 2005) . Electroporation of Sox2 and Sox3 in the chick neural tube has also been shown to inhibit endogenous and X-ngnr-1-induced neurogenesis (Bylund et al., 2003; Graham et al., 2003) . The association of Sox3 with proliferating cells has given rise to the idea that Sox3 promotes proliferation at the expense of differentiation. However, a direct interaction of Sox3 with the cell cycle machinery has not been established. Moreover, forced cell cycle arrest with HUA could not rescue the ectopic Sox3 expression and suppression of neuronal differentiation, suggesting that Xmxi1, and possibly Sox3, have a direct influence on neural cell fate specification.
The observation that Xmxi1 induces proliferation was somewhat surprising as previous studies have demonstrated that Mxi1, like other members of the Mad family, can induce growth arrest and can antagonize Myc activity when overexpressed in cell lines (Zervos et al., 1993; Schreiber-Agus et al., 1995; Wechsler et al., 1997) . From these studies and numerous others, a model of the Myc-Max-Network has been established, in which the Mad family of transcriptional repressors is thought to function exclusively to attenuate and restrict Myc activity. However, emerging evidence, predominately from in vivo experiments, suggests that this elegant but simplistic model needs to be reevaluated. The different Mad knockout mice (Mad1, Mxi1, and Mad3), with the exception of Mnt, exhibited only subtle effects on growth and differentiation and did not give rise to tumors, as would be predicted if the Mads were to function as Myc antagonists in vivo (Sadaghiani and Thiebaud, 1987; Toyo-oka et al., 2004; Grandori et al., 2000; Hurlin et al., 2003) . In addition, the Mad and Myc proteins are most likely to have both shared and unique target genes (O'Hagan et al., 2000) . The expression of some members of the Mad family, such as Xmad1, coincides with cells that have undergone terminal differentiation (Gehring et al., 2000; Bejarano et al., 2000; Roussel et al., 1996; Roy and Reisman, 1995; Pulverer et al., 2000; Juergens et al., 2005) . Mxi1, in contrast, is found in both proliferating (together with Myc) and differentiating cells (Zervos et al., 1993; Larsson et al., 1994; Hurlin et al., 1995) . The situation for Mxi1 is further complicated by the finding of multiple isoforms differing in their ability to act as transcriptional repressors and to inhibit Myc activity (Engstrom et al., 2004; Dugast-Darzacq et al., 2004) .
The distinct domains of expression during Xenopus embryogenesis described in this study and that of the previously described Xmads suggest that members of the Mad family of transcriptional repressors may have additional functions independent from the ability to antagonize Myc activity (Newman and Krieg, 1999; Juergens et al., 2005) . Moreover, the expression of Xmxi1 at neurula stages does not coincide with Myc expression, which is found in the premigratory neural crest cells and the anterior neural plate (Bellmeyer et al., 2003) , further suggesting a function for Xmxi1 during Xenopus embryogenesis other than acting as an Myc antagonist.
